Document is current
Any future updates will be listed below
-
Authors
Wehr, Michael C https://orcid.org/0000-0003-1770-8323
Hinrichs, Wilko
Brzózka, Magdalena M
Unterbarnscheidt, Tilmann
Herholt, Alexander
Wintgens, Jan P
Papiol, Sergi
Soto‐Bernardini, Maria Clara
Kravchenko, Mykola
Zhang, Mingyue
Nave, Klaus‐Armin
Wichert, Sven P
Falkai, Peter
Zhang, Weiqi
Schwab, Markus H
Rossner, Moritz J https://orcid.org/0000-0002-0667-3420
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (WE 5683/1‐1)
Deutsche Forschungsgemeinschaft (RO 4076/1‐1)
Deutsche Forschungsgemeinschaft (RO 4076/5‐1)
Deutsche Forschungsgemeinschaft (TRR58)
University of Münster Medical School (Zha3‐005‐14)
- License Information
-
More Information
Article History
Received: 13 February 2017
Revised: 26 June 2017
Accepted: 28 June 2017
First Online: 25 July 2017
Conflict of interest
: Systasy Bioscience GmbH holds the patent for the split TEV technique (termed splitSENSOR technology at Systasy Bioscience GmbH). M.C. Wehr, S.P. Wichert, and M.J. Rossner are co‐founders and shareholders of Systasy Bioscience GmbH, Munich, Germany.
